OncoLink - What's New this Week http://www.oncolink.org/whatsnew/ OncoLink - What's New this Week Sun, 04 Oct 2015 21:40:59 GMT Cyclophosphamide Oral Formulation (Cytoxan®, Neosar®, Endoxan®) http://www.oncolink.org/treatment/article.cfm?c=143&id=7243 Cyclophosphamides is a chemotherapy agent used in the treatment of lymphoma, leukemia, myeloma, ovarian cancer, neuroblastoma, retinoblastoma and breast cancer, or as a conditioning regimen for bone marrow transplant. Fri, 18 Sep 2015 04:00:00 GMT Sonidegib (Odomzo®) http://www.oncolink.org/treatment/article.cfm?c=143&id=7237 Sonidegib is a hedgehog pathway inhibitor used to treat locally advanced basal cell cancers. Fri, 14 Aug 2015 04:00:00 GMT Lenvatinib (Lenvima™) http://www.oncolink.org/treatment/article.cfm?c=143&id=7232 Lenvatininb (Lenvima) is a VEGF tyrosine kinase inhibitor used in the treatment of locally recurrent or metastatic, progressive, radioactive iodine-refractory differentiated thyroid cancer (DTC). Thu, 16 Jul 2015 04:00:00 GMT Self-Care Series for Oncology Professionals Session IV: Making It Work: Identifying and Embracing Your Self-Care Plan! http://www.oncolink.org/resources/article.cfm?c=1561&id=7211 This continuing education activity is designed to enable the learner to understand the challenges of working in oncology and how they can maintain a healthy work-life balance. Tue, 16 Jun 2015 04:00:00 GMT